F8 and hemophilia: Although ubiquitous expression of FVIII and secretion into the circulation induced high-titer inhibitory antibody production and eliminated functional FVIII activity, a single IO infusion of G-F8-LVs driven by a megakaryocyte-specific promoter produced long-term stable expression of hFVIII in platelets and corrected hemophilia phenotype for long term.